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ABSTRACT 
Recent findings suggest that leptin may be regulated in response to abrupt changes in energy 
homeostasis. Therefore, it is conceivable that transient changes in energy balance induced by 
exercise may also regulate leptin synthesis and secretion. As such, we hypothesized that acute 
increases energy expenditure (i.e. exercise), may regulate leptin concentrations in obese 
individuals. Fifteen healthy obese males underwent either a single exercise session of moderate 
intensity (58.4 % ± 4.0 of VO2max) for 60 min (n=8), or served as controls (n=7). The exercise 
session elicited an energy expenditure of 567±80 Kcal. No significant changes in plasma leptin 
(pre 23.5± 30.2; post 24.3± 34.3; 24h-post 34.9± 66.6; 48h-post 33.8±64.0 ng/ml), or insulin 
levels (pre 16.1± 9.2 vs. post 8.1± 9.1; 24h-post 14.3± 9.9; 48h-post 13.8± 10.2 µU/ml) were 
detected immediately after the intervention. Baseline plasma leptin levels were positively 
correlated with BMI (r=0.65; p<0.01), body weight (r=0.64; p<0.01), % body fat (r=0.90; 
p<0.01) and were negatively correlated with VO2max (r=-0.82; p<0.01). The results of the 
present study suggest that acute exercise of moderate intensity and duration may not affect 
leptin concentration. 
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INTRODUCTION
The isolation of the ob gene in mice opened new horizons in the pathophysiology of obesity 
(Zhang et al., 1994). Leptin, the only known ob gene product, is a hormone that is secreted 
primarily by white adipose tissue (Kolaczynski et al., 1996) and postulated to act as part of a 
feedback signal to the central nervous system, in particular the satiety center in the 
hypothalamus. This feedback signal functions primarily to ensure that energy intake and output 
are balanced over time (Schwartz, Seeley, Campfield, Burn, & Baskin, 1996).  
Serum leptin concentration is primarily, but not exclusively, determined by the amount of 
adipose tissue in the body. As such, obese individuals (BMI >30 kg/m2) have on average four-
fold more serum leptin concentration than their lean counterparts (Considine et al., 1996). This 
difference in serum leptin levels may be explained by the greater concentration of ob mRNA 
found in adipocytes taken from obese individuals (Considine et al., 1996; Lonnqvist, Arner, 
Nordfors, & Schalling, 1995). In addition to adipose tissue volume, gender has been shown to 
influence serum leptin.  Females have higher concentrations than males and these differences 
exist after adjusting for differences in adiposity (Couillard et al., 1997; Hickey et al., 1996). 
Regular physical activity has been shown to be effective in the prevention and treatment of 
obesity and its comorbidities (DiPietro, 1999; Rippe & Hess, 1998). Therefore, it is reasonable 
to speculate that chronic physical activity may directly or indirectly regulate leptin metabolism. 
Chronic exercise training (9-36 weeks) (Kohrt, Landt, & Birge, Jr., 1996; Kraemer et al., 1999), 
however, failed to demonstrate an independent effect on serum leptin levels in  obese women. 
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Decreases in serum leptin were observed only as a result of an exercise-induced reduction in 
body fat mass (Christensen, Svendsen, Hassager, & Christiansen, 1998; Thong, Hudson, Ross, 
Janssen, & Graham, 2000). Similarly, diet-induced fat loss decreased serum leptin 
concentrations proportionally to the reduction in adiposity in obese men and women (Geldszus 
et al., 1996; Havel et al., 1996; Wadden et al., 1998). It should be noted however, that chronic 
exercise training often results in significant decreases in adipose tissue, especially in obese 
individuals (Wilmore et al., 1999). As such, it is difficult to evaluate the independent effect of 
exercise on leptin levels.  
The effect of acute exercise on serum leptin has been examined by several investigators. Acute 
exercise is unlikely to alter body fat mass and therefore may operate independently of adiposity 
in altering leptin metabolism. It has been proposed that acute exercise may play a role in leptin 
metabolism by transiently disrupting the equilibrium between energy intake and expenditure. 
For example, significant decreases in serum leptin concentrations (32%) have been reported in 
lean trained subjects immediately after a 36-hour ultra-distance race (Landt et al., 1997). These 
data suggest that a substantial energy deficit does result in changes in serum leptin levels, but 
does not shed light on exercise of a more typical duration, and therefore energy expenditure. 
The majority of early studies in lean sedentary males and females reported little or no effect on 
serum leptin levels when measured immediately following an exercise bout of shorter duration 
(10 to 60 minutes) and moderate intensity (50-75% of maximal oxygen consumption) (Perusse 
et al., 1997; Racette, Coppack, Landt, & Klein, 1997; Weltman et al., 2000). The absence of 
significant changes in circulating leptin immediately after a single exercise bout does not 
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preclude the possibility of a delayed effect of exercise on serum leptin levels. A significant 
decrease (34%) in plasma leptin levels in lean trained males was reported, 44 hours following a 
2-hour treadmill session at 75% of VO2 max (Tuominen et al., 1997). Similar delayed (48h 
post) responses in leptin levels were observed in a recent study in which lean trained males 
exercised at 70% of their VO2 max, and expended between 800 to 1,500 Kcal (Essig, Alderson, 
Ferguson, Bartoli, & Durstine, 2000). Finally, a decrease in leptin concentration 24-48 hours 
after a 2-hour exercise session (50% Vo2 max) has been reported in lean sedentary males (van 
Aggel-Leijssen, van Baak, Tenenbaum, Campfield, & Saris, 1999). These delayed effects on 
serum leptin levels may be due to factors other than adiposity, since a single bout of exercise of 
moderate duration and intensity has not been shown to alter body fat. Fasting and refeeding 
studies have also indicated a transient effect on serum leptin concentration. For example, short 
term fasting (12-36h) significantly decreased serum leptin concentration (Boden, Chen, 
Mozzoli, & Ryan, 1996). Nevertheless, these changes in serum leptin levels were restored to 
pre-fasting levels (within 24h) by successive refeeding (Kolaczynski et al., 1996; Weigle et al., 
1997). Based on the above observations it is reasonable to speculate that acute fluctuations in 
energy balance (i.e. caused by exercise, and/or fasting) may play a role in the short-term 
regulation of leptin.  
In summary, the role of leptin in human obesity is not completely understood. Among other 
factors, exercise may have a potential involvement in leptin metabolism. The effects of exercise 
in leptin metabolism may be of particular clinical significance for obese individuals. The role 
of chronic exercise training on circulating leptin levels is unclear, since changes in leptin levels 
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are often the result of an exercise-induced decrease in fat mass. The effects of acute exercise, if 
any, are independent of changes in adipose tissue and may clarify how regular exercise may 
affect leptin metabolism.  
In summary, in order to clarify the role of chronic exercise on systemic leptin levels in obese 
individuals, the effects of acute exercise need to be adequately characterized. Interestingly, to 
date, no studies are available that address the effects of acute exercise on leptin metabolism in 
obese individuals. Therefore, this is the first attempt to characterize the effects of acute exercise 
on systemic leptin levels in obese individuals. Such an attempt may shed new light on the role 
of exercise in leptin metabolism and the physiological mechanisms that link leptin metabolism 
to obesity. 
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REVIEW OF THE LITERATURE 
Introduction 
Obesity has emerged as a serious health problem in Western societies, affecting up to 35% of 
the adult population in the United States. Physiologically, obesity is a disorder characterized by 
excess body fat accumulation, developing when energy intake exceeds energy expenditure 
(Ostlund et al., 1996). It is believed that obesity is a multi-factorial disorder influenced by 
metabolic abnormalities, dietary patterns, lack of adequate amount of physical activity and 
genetic defects (Weinsier et al., 1995).  
It has been suggested that regulation of body weight may involve the direct or indirect actions 
of several hormones (i.e. insulin, glucocorticoids). These hormones, after receiving information 
from the peripheral tissues, modulate the neuronal pathways in the hypothalamus that have 
potent effects on both energy intake and expenditure. This feedback system between the brain 
and the energy status of the body functions primarily to ensure that energy intake and 
expenditure are matched over time, maintaining a stable body weight.  
In 1953, Kennedy proposed the ‘lipostatic theory’ in which total body mass is maintained by 
regulating body fat content (Kennedy, 1953). He suggested that an unknown circulating factor 
provides the hypothalamus with information on the amount of body fat stores. If changes in 
adiposity occur over time, the hypothalamus would make appropriate adjustments in food 
intake in order to restore body fat content. 
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Leptin: structure, synthesis and degradation 
In the past two decades, several advances in molecular biology and biotechnology have allowed 
the study and identification of a number of genes linked to obesity (Bessesen & Faggioni, 
1998). Among them is the identified obese gene (ob gene) and its protein product leptin (OB 
protein) (Zhang et al., 1994). The discovery of leptin provided a molecular basis for the 
aforementioned lipostatic theory of energy balance regulation. 
The ob gene was identified by positional cloning and consists of 3 exons and 2 introns, which 
encode a 4.5 kb mRNA expressed primarily in white adipocytes. Emerging evidence, however, 
suggests that leptin transcription and translation also occur in the placenta and the 
gastrointestinal tract (Masuzaki et al., 1997). The ob gene product, leptin, is a 167 amino acid 
peptide with an amino-terminal secretory signal sequence of 21 amino acids, which is 
subsequently removed prior to release of leptin into the circulation. Thus, circulating leptin is a 
peptide of 146 amino acids with a molecular mass of 16 kDa. Leptin is secreted into the 
circulation, where it can be measured using an immunoprecipitation assay or a 
radioimmunoassay (Ma et al., 1996; Maffei et al., 1995). Furthermore, serum leptin circulates 
in part bound to transport proteins in the serum of both rodents and humans (Houseknecht et 
al., 1996), but obese individuals have most of leptin circulating in its free bioactive form (Sinha 
et al., 1996). Human leptin is 84% homologous to the mouse protein and has a half-life of 
24.9±4.4 min with no differences between obese and lean individuals (Klein, Coppack, 
Mohamed-Ali, & Landt, 1996). The short half-life of leptin in the circulation is mainly 
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determined by renal clearance, which is mediated by renal flow and glomerular filtration.    
Biological functions of Leptin  
It has been postulated that leptin acts as part of a feedback signal to the central nervous system 
(CNS), in particular the satiety center in the hypothalamus (Kolaczynski et al., 1996). This 
speculation is further supported by the existence of a saturable transport system for leptin 
across the blood-brain barrier, mainly at the choroid plexus and the hypothalamus (Banks, 
Kastin, Huang, Jaspan, & Maness, 1996). After entering the CNS, leptin binds to specific 
receptors found in the arcuate nucleus and in the ventromedial and dorsomedial hypothalamus 
(Schwartz, Seeley, Campfield, Burn, & Baskin, 1996). The leptin receptor (ob-R) belongs to 
the family of cytokine receptors (i.e. hGH, IGF-1) and is likely to signal via the JAK-STAT 
signal transduction pathway in the hypothalamus. The leptin receptor gene encodes at least five 
alternatively spliced forms, with two of these forms (one short and one long) found in the 
hypothalamus. The short ob-R may be involved in leptin transport and the long ob-R may 
mediate leptin action (Halaas & Friedman, 1997; Tartaglia et al., 1995). 
 In rodents, leptin has substantial effects on food intake and energy expenditure. Injection of 
leptin in ob/ob mice (absence of functional leptin) resulted in reduced body weight, fat mass, 
and percent body fat mostly mediated through a reduction in food intake (Pelleymounter et al., 
1995). These effects are exhibited via the orexigenic neuropeptide Y (NPY) (Schwartz, Seeley, 
Campfield, Burn, & Baskin, 1996). Leptin has been shown to decrease both the release of NPY 
and the expression of NPY mRNA in vivo (Stephens et al., 1995). Nevertheless, NPY is not the 
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only target of leptin in the hypothalamus. Leptin has been shown to up-regulate the secretion of 
corticotropin-releasing hormone (CRH), pro-opiomelanocortin (POMC), cocaine-and 
amphetamine-regulated transcript (CART) and other peptides which have been shown to 
increase or maintain energy expenditure and thermogenesis in rats (Costa et al., 1997; 
Thornton, Cheung, Clifton, & Steiner, 1997).  
Interestingly, leptin may also act peripherally, with receptors found in numerous non-
hypothalamic tissues. Administration of recombinant leptin restored the fertility of the 
otherwise infertile ob/ob mice (Chehab, Lim, & Lu, 1996). Moreover, leptin appears to inhibit 
insulin secretion from the β-cells of the pancreas (Fehmann et al., 1997), stimulate glucose 
utilization in the skeletal muscle (Kamohara, Burcelin, Halaas, Friedman, & Charron, 1997), 
stimulate lipolysis in adipocytes (Fruhbeck, Aguado, & Martinez, 1997) and glucose transport 
across the small intestine (Lostao, Urdaneta, Martinez-Anso, Barber, & Martinez, 1998). 
Finally, leptin may be a stimulatory factor in haematopoiesis (Gainsford et al., 1996).  
Methods of Leptin Detection and Measurement 
Two methods have been developed to measure total human leptin in serum, plasma or tissue 
culture media; a) Human Leptin radioimmunoassay (RIA) and b) Human Leptin Enzyme 
Linked Immunosorbent Assay (ELISA). 
In radioimmunoassay, a fixed concentration of labeled tracer antigen is incubated with a 
constant dilution of antiserum such that the concentration of antigen binding sites on the 
antibody is limited. For example, only 50% of the total tracer concentration may be bound by 
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antibody. If unlabeled antigen is added to this system, there is competition between labeled 
tracer and unlabeled antigen for the limited and constant number of binding sites on the 
antibody. Thus, the amount of tracer bound to antibody will decrease as the concentration of 
unlabeled antigen increases. This can be measured after separating antibody-bound from free 
tracer and counting one or the other, or both fractions. A calibration or standard curve is set up 
with increasing concentrations of standard unlabeled antigen and from this curve the amount of 
antigen in unknown samples can be calculated. Thus, the four basic necessities for a 
radioimmunoassay system are: a specific antiserum to the antigen to be measured, the 
availability of a radioactive labeled form of the antigen, a method whereby antibody-bound 
tracer can be separated from the unbound tracer, and finally, an instrument to count 
radioactivity. 
Human Leptin ELISA is a two-site immunoassay using a high affinity polyclonal capture 
antibody and a monoclonal detecting antibody.  Signal is derived by monitoring (405 nm) 
alkaline phosphatase activity in the presence of the substrate p-nitrophenyl phosphate. Human 
leptin ELISA assay is based, sequentially, on: 1) capture of human leptin molecules from 
samples to the wells of a microtiter plate coated by pre-titered amount of polyclonal rabbit anti-
human leptin antibodies, 2) wash away of unbound materials from samples, 3) binding of a 
biotinylated monoclonal antibody to the captured human leptin, 4) conjugation of alkaline 
phosphatase to biotinylated antibodies, 5) wash away of free antibody-enzyme conjugates, and 
6) quantification of immobilized antibody-enzyme conjugates by monitoring alkaline 
phosphatase activities in the presence of the substrate p-nitrophenyl phosphate. The enzyme 
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activity is measured spectrophotometrically by the increased absorbency at 405 nm due to 
production of the yellow colored product p-nitrophenol. Since the increase in absorbency is 
directly proportional to the amount of captured human leptin in the unknown sample, the latter 
can be derived by interpolation from a reference curve generated in the same assay with 
reference standards of known concentrations of human leptin. This assay produces results 
identical to the gold standard Human Leptin RIA and offers an alternative for laboratories 
interested in reducing use of radioisotopes yet maintaining data consistency to previously 
published RIA results. 
Leptin regulation in humans 
The physiologic role of leptin in humans has not yet been fully elucidated. Serum leptin 
concentration is related to the amount of adipose tissue in the body (Considine et al., 1996; 
Maffei et al., 1995). Moreover, there is evidence that the amount of ob mRNA expressed by the 
adipose tissue is determined by the number and size of adipose cells. Thus, obese individuals 
have proportionally greater concentration of ob mRNA in their adipocytes, which accordingly 
increases the rate of leptin production. As such, obese individuals (BMI >30kg/m2) have on 
average four-fold serum leptin concentration than their lean counterparts (Considine et al., 
1996). Since leptin is proportionally related to body fat content it is reasonable to expect that 
changes in leptin concentration will parallel changes in body fat mass. Diet-induced weight loss 
decreases leptin concentration proportionally to the reductions in body fat mass (Geldszus et 
al., 1996;Wadden et al., 1998). In obese subjects, however, changes in leptin concentration with 
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weight loss are more dramatic, given that a fixed reduction in adiposity induces a 3 to 10-fold 
decrease in leptin concentration (Havel et al., 1996; Wadden et al., 1998).     
Nevertheless, a large portion of the variability observed in leptin concentrations between 
different individuals cannot be explained by differences in body fat alone. Gender influences 
serum leptin independent of adiposity. As such females have higher concentrations of 
circulating leptin than males (Castracane, Kraemer, Franken, Kraemer, & Gimpel, 1998; 
Couillard et al., 1997). Moreover, plasma leptin in women increases during the luteal phase of 
the menstrual cycle, adding more evidence to the hypothesis that sex hormones (i.e. estradiol, 
progesterone) may regulate leptin secretion (Cella, Giordano, & Cordera, 2000). Similarly, it 
has been demonstrated that testosterone in men may have a suppressive effect on leptin 
production by the adipocytes (Behre, Simoni, & Nieschlag, 1997; Haffner, Miettinen, 
Karhapaa, Mykkanen, & Laakso, 1997). In a recent report, however, gender difference in leptin 
concentrations were not apparent when the relationship between log transformed plasma leptin 
levels and Dual Energy X-ray Absorbance (DEXA)-derived percent body fat were examined, 
indicating that the method of assessing body composition may greatly affect the relationship 
between leptin and adiposity (Jensen, Hensrud, O'Brien, & Nielsen, 1999).  
Conflicting reports exist regarding the association between circulating leptin levels and aging. 
In two recent studies, BMI and fat mass-adjusted leptin levels were found to gradually decline 
with aging, with more notable reduction in women compared to men (Isidori et al., 2000; 
Neuhauser-Berthold et al., 2000). In contrast, others have reported no effect of age on the 
relationship between circulating leptin and body fat mass (Roberts et al., 1997; Sumner, 
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Falkner, Kushner, & Considine, 1998).   
Leptin in humans may also be altered by circadian rhythms. Plasma leptin concentrations reach 
maximal values shortly after midnight (Sinha et al., 1996). These fluctuations in plasma leptin 
concentrations were not altered between normal-size meals, suggesting that meal ingestion does 
not interfere with leptin metabolism, and therefore it is unlikely that leptin can act as an acute 
satiety factor (Considine et al., 1996). Short-term fasting, however, decreases leptin levels 
without any appreciable changes in body fat content (Boden, Chen, Mozzoli, & Ryan, 1996). 
Leptin levels begin a steady decline after 12h of fasting, reaching a nadir at 36h and returning 
to pre-fasting levels 6-12h after refeeding (Kolaczynski et al., 1996; Pratley, Nicolson, 
Bogardus, & Ravussin, 1997; Weigle et al., 1997). Leptin level alterations with fasting and 
refeeding may be dependent on insulin, since these changes occur parallel to changes in plasma 
insulin (Patel, Koenig, Kaplan, & Hooi, 1998). The majority of the data, however, suggest that, 
at least short-term, insulin does not have an effect on leptin secretion in humans. A 3-hour 
euglycemic hyperinsulinemic clamp did not increase leptin mRNA levels in human adipose 
tissue (Vidal et al., 1996). Similarly, neither a hyperglycemic (approximately 10 mmol/L) nor a 
hyperinsulinemic- euglycemic (400-3000 pmol/L) clamp affected plasma leptin levels (Ryan & 
Elahi, 1996). Finally, leptin gene expression and secretion in humans may be regulated by 
glucocorticoids (Casanueva & Dieguez, 1999) and catecholamines (Del Rio, 2000). 
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The effects of acute exercise training on leptin concentrations in humans 
The fact that energy intake can influence leptin levels may suggest that energy expenditure may 
also have a potentially independent role in leptin metabolism. Many studies have addressed the 
effects of prolonged exercise (>120min) on leptin levels. For example, significantly decreased 
serum leptin concentrations (32%) was reported immediately post-exercise, when lean trained 
males had participated in a 36-hour ultra-distance race (Landt et al., 1997). In addition, energy 
expenditure of 2800 Kcal induced by a Marathon run reduced serum leptin levels in male 
athletes (Leal-Cerro et al., 1998). No significant changes in serum leptin levels were reported in 
highly trained male athletes immediately after a 20-mile run, suggesting that relatively chronic 
changes in energy expenditure are required to alter leptin metabolism (Hickey et al., 1996),. 
Similarly, acute exercise of shorter duration (60 minutes) did not change plasma leptin 
concentrations in sedentary male subjects after a moderate-intensity (50% of maximum heart 
rate) cycle ergometer training (Racette, Coppack, Landt, & Klein, 1997) or treadmill exercise 
(Torjman, Zafeiridis, Paolone, Wilkerson, & Considine, 1999). Moreover, 30 minutes of acute 
exercise at varying intensities and caloric expenditures, did not affect leptin concentrations in 
active men during or immediately after the recovery (Weltman et al., 2000). Finally, a maximal 
exercise test (12-15 min) did not induce any changes in plasma leptin levels in lean sedentary 
men and women (Perusse et al., 1997). In these studies, leptin was measured only before, 
during, and immediately after exercise. Thus, the above studies could not determine any 
delayed alterations in leptin concentration that could be related to the exercise stimulus per se, 
or the exercise-induced negative energy balance. 
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A significant decrease (34%) in plasma leptin levels was reported in lean trained males, 44 
hours following a 2-hour treadmill session at 75% of their VO2 max (Tuominen et al., 1997). 
Similar delayed responses in leptin have been confirmed in a recent study in which lean trained 
males exercised at 70% of their VO2 max requiring a caloric expenditure between 800 to 1,500 
Kcal (Essig, Alderson, Ferguson, Bartoli, & Durstine, 2000). Finally, in lean sedentary males, 
leptin concentration decreased 24-48 hours after a 2-hour exercise session (50% Vo2 max) (van 
Aggel-Leijssen, van Baak, Tenenbaum, Campfield, & Saris, 1999). These results may highlight 
a potentially important time delay in the response of leptin following acute exercise.  
The effects of chronic exercise on leptin concentrations in humans 
It has been previously mentioned that diet-induced fat loss is accompanied by significant 
reductions in circulating leptin levels in humans. It is not clear whether exercise-induced 
changes in circulating leptin levels depend on the alterations in fat mass. The effects of 7 
consecutive days of exercise training on leptin were examined in lean, sedentary subjects 
(n=30). Subjects exercised continuously for 60 minutes/day at 70%-75% of their VO2max and 
consumed a normal diet during the exercise-training period. Exercise training did not alter body 
mass or plasma leptin levels (Houmard, Cox, MacLean, & Barakat, 2000). Similarly, in another 
study in which body weight remained unchanged, 9 weeks of aerobic exercise did not 
significantly alter serum leptin levels in obese women (Kraemer et al., 1999b). In 
postmenopausal women, a 36-week endurance training program (Kohrt, Landt, & Birge, Jr., 
1996) or a 12-week diet and exercise intervention (Christensen, Svendsen, Hassager, & 
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Christiansen, 1998) decreased serum leptin levels proportionally to the exercise-induced and/or 
diet-induced decreases in fat mass. Similarly, in obese men decreases in plasma leptin levels 
were observed after 12 weeks of diet-induced or exercise-induced weight loss (Thong, Hudson, 
Ross, Janssen, & Graham, 2000). Although the majority of data regarding the effects of chronic 
exercise on circulating leptin levels support the notion that there is no profound effect of 
exercise per se, a few studies have demonstrated an independent effect of chronic exercise on 
systemic leptin levels. Sixteen months of exercise training in obese men resulted in reductions 
in leptin concentration independent of body fat and insulin levels (Pasman, Westerterp-
Plantenga, & Saris, 1998). These independent effects were observed only after the 10th month 
of the study, indicating that probably the duration of exercise training was important for the 
observed results. Similarly, other studies have proposed that a gender-dependent effect of 
exercise training on serum leptin levels may exist. The effects of a 20wk endurance exercise 
program on leptin levels in 97 men and women were examined (Perusse et al., 1997). 
Endurance training was associated with a reduction in circulating levels of leptin in men but not 
in women. After adjustment for fat mass changes, however, the effects of training were no 
longer significant for the men. In contrast, serum leptin concentrations decreased by 17.5% in 
lean females after 12 weeks of aerobic exercise training (4 days/week, 30-40min/day) but was 
not significantly reduced in lean males (Hickey et al., 1997). These data may suggest that 
exercise training may induce a greater effect on systemic leptin levels in females than in males. 
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Discussion 
The discovery of leptin introduced new insights into the regulation of body mass and the 
pathophysiology of human obesity. However, the significance of leptin in the regulation of 
body mass in humans is not fully understood. Circulating leptin increases in response to 
increased fat mass and, under normal conditions, affects the appetite center in the 
hypothalamus to reduce food intake. This mechanism ensures that when dramatic increases in 
fat mass occur, food intake will be reduced to prevent further increases in adiposity and 
eventually restore the previous set point of body mass.  
Exercise training, acute and chronic, has been proposed as one of the regulatory factors that 
may be involved in leptin metabolism. The effect of a single exercise bout on circulating leptin 
is controversial. Serum leptin concentration decreased in response to prolonged vigorous 
exercise in two studies (a marathon and an ultra-marathon race). Nevertheless, no changes in 
circulating leptin were observed immediately after an acute exercise bout of shorter duration 
and moderate intensity. This suggests that a substantial negative energy deficit may result in 
acute changes in serum leptin levels. It has also been suggested that the decreases in leptin 
levels after a prolonged exercise session could be attributed to the low energy availability 
caused by the exercise energy expenditure and not to the exercise stress per se (Hilton & 
Loucks, 2000). The lack of change in the circulating leptin concentration immediately 
following short-term exercise does not preclude the possibility of a delayed effect that may be 
manifested following exercise. For instance, a decrease in serum leptin levels was manifested 
24 to 48 hours after a single exercise bout. These effects were independent of changes in fat 
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mass or fluctuations in energy intake. Hence, it may be suggested that increased exercise-
induced energy expenditure may be the major reason for the observed decrease in leptin 
concentration during recovery. These changes in leptin may mediate the restoration of energy 
homeostasis during recovery from periods of increased energy expenditure (i.e. acute exercise). 
It is of particular note, however, that despite the involvement of leptin metabolism in human 
obesity no studies, to date, have addressed the effects of an acute exercise bout on systemic 
leptin concentration in obese individuals.    
The data regarding the effects of chronic exercise training on circulating leptin levels are 
equivocal. It has been suggested that chronic exercise, in the absence of a decrease in body 
mass, does not alter leptin levels. Therefore, no independent effect of chronic exercise could be 
demonstrated on circulating leptin levels in obese subjects. It is well documented that chronic 
exercise training often decreases fat mass in obese individuals (Wilmore et al., 1999). 
Therefore, when alterations in circulating leptin were observed, it was proposed that they 
represent the secondary effects of exercise on energy balance and not the exercise stimulus per 
se. In contrast, others have reported independent effects of chronic exercise on leptin levels. 
For instance, it has been proposed that the effects of chronic exercise on circulating leptin 
levels may be dose-dependent (i.e. greater energy deficit). The duration and the number of 
exercise hours, however, may only reflect increased energy expenditure and not necessarily an 
independent exercise effect. Others have reported that serum leptin concentration decreases 
after chronic exercise training in females but not in males, suggesting a gender-dependent 
effect. Caloric intake was not well controlled in this study and therefore these gender 
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differences may be secondary to fluctuations in energy balance and not the result of the 
exercise training. 
In conclusion, the effects of acute and chronic exercise on systemic leptin levels remain to be 
determined. Future exercise studies should adequately control energy intake and or 
expenditure, and therefore results can be interpreted independently of changes in energy 
balance. Similarly, technologically advanced methods of assessing body composition (i.e. 
DXA) should be used in order to more accurately evaluate the relationship between fat mass 
and leptin. Chronic exercise studies should be specifically designed to examine the dose-
response relationship between exercise and circulating leptin levels and whether this 
relationship is gender specific. Moreover, it remains to be elucidated whether acute exercise 
has an independent effect on leptin levels and the time course of these effects. Finally and more 
importantly, the effects of acute exercise on systemic leptin levels should be addressed in obese 
individuals, since these effects may be of particular clinical significance for this population.  
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METHODS 
Subjects 
Fifteen adult (age 18-35) obese males (BMI≥30 kg/m2) voluntarily participated in this project, 
after signing an informed consent form approved by the Institutional Review Board (IRB) of 
the University of Central Florida. Participants were randomly assigned to either an 
experimental or a control group.  Qualified participants were sedentary, non-smokers and had 
no known cardiovascular, pulmonary, metabolic, or chronic diseases.   
Screening and qualifying visits 
All participants underwent a screening procedure, which included a health/medical 
questionnaire, anthropometric and body composition measurements, a fasting plasma glucose 
(FPG) test, a pulmonary function test (PFT), a graded exercise test (GXT), a 3-day self-
reported diet record and a maximal aerobic capacity test (ACT) that measured their VO2max. 
The administration of the health/medical questionnaire evaluated current and past medical 
history, as well as, exercise, dietary and lifestyle habits. Anthropometric measurements 
included body weight (BW), body height (BH), BMI and waist-to-hip ratio (WHR). BW was 
measured on a balance-beam scale accurate to 0.1 lb. BH was obtained to the nearest 0.1 cm 
using a scale-mounted stadiometer. BMI was calculated by dividing body weight by body 
height squared (Kg/m2). Waist and hip circumferences were measured at the smallest 
circumference between the rib cage and iliac crest and at the level of the widest gluteal 
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protuberance respectively, with the subject in standing position. Body composition included 
percentage of body fat, fat mass and lean body mass and was determined by dual-energy X-ray 
absorptiometry (DPX MD+, Lunar Co.) as previously described by others (Jensen et al., 1993). 
Body composition tests were also repeated one day before the exercise intervention (Day7). 
Plasma glucose was determined (Day 1), after an overnight fast. Plasma glucose was measured 
(YSI Glucose/L-Lactate Analyzer 2300 STAT) after centrifugation of a blood sample for 30 
minutes at 4oC. The PFT was performed using closed loop spirometry (SuperSpiro Spirometer, 
Micro Direct Inc.). The criteria for determining possible ventilatory limitations have been 
previously described by others (Younes, 1984).  
All subjects underwent a sub-maximal, 12-lead Graded Exercise Testing (GXT) (Day 2). The 
GXT was performed on a Quinton Max-1 Exercise Testing System (GE Marquette Electronics) 
with the presence of an ACSM Program DirectorSM Certified and other certified personnel. 
Subjects, after following a warm-up period consisting of light walking at 1.7 mph and 5% 
grade, were tested employing the Bruce protocol (Bruce, 1971). The test was terminated when 
subjects reach 85% of their age-predicted heart rate maximum (HR max), and followed by a 
recovery period until heart rate (HR) and blood pressure (BP) decreased to the baseline values.  
Furthermore, subjects were asked to keep a 3-day self-reported diet record (From initial 
Screening to Day 3), which included a detailed description of the portion size, food groups, and 
time of the meals. Participants were instructed on how to correctly record and report their food 
intake. Diet records were analyzed for caloric content and macronutrient composition 
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(NutriBase 2001 Clinical v.3x, CyberSoft, Inc.).  
Finally, subjects underwent a maximal ACT (Day 3) using a MAX-1 Cart (Physio-dyne 
Instrument Corp). The maximal ACT protocol began with a warm-up period consisting of light 
walking (2.5 mph, 3%) and proceeded by progressively increasing the workload (1-2 METs) 
every 3 minutes. The maximum ACT was performed in order to measure peak oxygen 
consumption (peak VO2). The test was terminated if requested by the subject, or when at least 
two of the following criteria were met: i) failure to increase VO2 more than 150ml/min with an 
increase in workload, ii) respiratory exchange ratio (RER) over 1.1, and iii) HR above 90% of 
HRmax. 
Experimental Design 
A randomized pretest-posttest control group design was used in this study. Participants were 
assigned in groups randomly by alternating participants between the control and experimental 
group. Both the experimental and the control group were subjected to all screening tests, blood 
sampling and dietary protocols. Only the experimental group participated in the exercise 
intervention. A schematic of the design is depicted below: 
Table 1: Schematic of the experimental design 
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Blood Sampling and Analysis 
All fasting blood samples (~10ml) were drawn from participants of both groups before 9:00 
AM (# 1-3, 5 and 6) except the post-exercise blood sample (# 4), which was taken immediately 
after the completion of the exercise from the participants of the experimental group. At the day 
of intervention, blood samples (# 3-4) were taken from the participants of the control group 2 
hours apart (i.e. 8:00 a.m. and 10:00 a.m.). This assured that the time of blood sampling of the 
control group corresponded to the pre/post exercise blood sampling of the experimental group. 
Blood samples before the day of intervention (# 1-3) were used to test whether there was 
significant daily variability of the measured variables (i.e. leptin and insulin). Subjects were 
instructed to abstain from any physical activity the day before the test (except the experimental 
group for all the post-exercise blood samples) and fast 12h before blood sampling. Hematocrit 
(Hct) and hemoglobin (Hb) content were measured in pre and post-exercise blood samples and 
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were used to detect any changes in plasma volume (Dill & Costill, 1974). Plasma blood 
samples were mixed with EDTA to prevent clotting and were centrifuged immediately. Serum 
blood was centrifuged after 30 min at room temperature. All blood samples were stored at –800 
Celsius. Leptin and insulin concentrations determined by ELISA (Linco Research, St. Louis 
MI). 
Diet 
The data gathered from the 3-day self-reported dietary record were compared to the predicted 
total daily energy expenditure (TDEE) adjusted for physical activity. TDEE was calculated as 
predicted resting energy expenditure (REE) times an activity factor of 1.5. REE was calculated 
as 370 + [21.6 x (Fat-Free Mass)] (Cunningham, 1991; Warwick, Edmundson, & Thomson, 
1988). After estimation of TDEE, participants continued to report a dietary record on a daily 
basis and until the end of the study. An average energy intake of ± 15% of the predicted TDEE 
was considered acceptable for participation in the study.  
Exercise Protocol 
 On the day of the exercise intervention (Day 8), all participants arrived at the Exercise 
Physiology Laboratory no later than 8:00 a.m., after an overnight fast and having abstained 
from any physical activity for at least 4 days. The experimental group performed a single 
exercise bout on a motorized treadmill at 50-60% of their measured VO2 max for 60 minutes 
with 5-10 min warm-up included. The exercise intensity was progressively increased until the 
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desired intensity (50-60% VO2peak) was achieved. The targeted exercise intensity was verified 
by collecting expiratory gases. Moreover, HR was continuously measured using a HR monitor 
(Polar Inc.). The net exercise-induced energy expenditure was estimated from expiratory gases 
collected for 3 minutes in 15-minute intervals, minus the resting energy expenditure 
(3.5ml/kg/min) during that time. Additionally, their BW was measured pre and post exercise 
for corrections in blood volume.  
Statistical Analysis 
Differences in the dependent variable between were examined via analysis of variance 
(AVOVA) with repeated measures. Significant main effects or interactions were probed using a 
Tuckey’s post-hoc test. Statistical significance for mean differences was set at the p<0.05 level.  
All data analysis was performed using SPSS version 12.0 
Definitions of inclusion criteria 
Obesity: Individuals with body mass index (BMI) equal or more than 30.0 Kg/m2. 
Sedentary: Individuals who have not engaged in vigorous (>6 METS) physical activity more 
than one time per week for the prior 6 months. 
Non-smoker: Individuals who have never smoked, and/or have quit smoking at least six months 
prior to the study. 
Stable body weight: Individuals who have refrained from any dietary program, that caused or 
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intended to cause weight reduction, for at least three months prior to the investigation. 
Hypertension: Resting blood pressure equal or over 140/90 mmHg that is confirmed by two 
different measurements in separate days and/or on any antihypertensive drugs. 
Type 2 diabetes mellitus: Fasting plasma glucose (FPG) equal or over 126 mg/dl (7.00 mmol/l) 
confirmed on a subsequent day. 
Cardiovascular diseases: Individuals who have been diagnosed with cardiac arrhythmias, 
stroke, peripheral vascular disease, valvular heart disease, congestive heart failure and/or have 
had a heart attack, a coronary bypass or other cardiac surgery.  
Pulmonary diseases: Individuals who have been diagnosed with asthma, emphysema, 
bronchitis, or pneumonia. 
Metabolic diseases: Individuals who have been diagnosed with diabetes mellitus or a thyroid 
disease. 
Chronic diseases: Individuals who have been diagnosed with renal failure, hepatitis, 
osteoarthritis, or other orthopedic diseases. 
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RESULTS 
Anthropometric measurements, dietary and exercise data 
Sixteen participants completed the study. One subject, however, was excluded from statistical 
analysis due to elevated fasting plasma glucose levels (see methods). Upon analysis of the data, 
two of the remaining participants were also found to have baseline plasma leptin concentrations 
exceeding 100ng/ml. To eliminate the possibility that results are skewed, the data were also 
statistically analyzed excluding the two aforementioned participants. The results were not 
different regardless of the presence or absence of the two participants with high leptin levels, so 
their data are included in the final analysis. No significant differences in body weight, BMI, % 
fat, and oxygen consumption (Table.2) were detected between the control and experimental 
group. No changes in body composition, or body weight were observed during the week prior 
to the intervention. Analysis of the initial 3-day dietary record showed that the daily caloric 
intake of all participants was appropriate for maintaining their current body weight (see 
methods), and no significant energy fluctuations were observed thereafter (Table. 5). The 
experimental group completed a single exercise bout for 1-hour at an average exercise intensity 
(excluding warm-up period) ranging between 53-66% (58.4%± 4.0) of the measured VO2max 
and an average HR intensity (excluding warm-up period) ranging between 126-152 beats/min 
(140.0± 7.8 beats/min) (Table.3). This intensity resulted in total energy expenditure (including 
warm-up period) ranging between 480-720 Kcal (567±80 Kcal).  
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Exercise effects on leptin and insulin concentrations 
No significant differences in circulating plasma leptin or insulin were observed across pre-
exercise measurements (Time points observed: Baseline1, Baseline 2, and Pre-exercise), or 
between the two groups (Table.4). These results indicate that both leptin and insulin did not 
show any significant daily variation and were stable over the measured time points preceding 
the exercise bout. No significant differences in plasma leptin levels were observed immediately 
after the exercise bout or on the days following the session (i.e. 24-h, and 48-h post-exercise) in 
the exercise group. A significant (p=0.011) quadratic time by group interaction was observed in 
plasma insulin concentration which was further evaluated using repeated measures between 
two sets of consecutive time points [i.e. set A: 1) pre-exercise, 2) post-exercise, 3) 24h post and 
set B: 1) post-exercise, 2) 24h post, 3) 48h post]. To avoid a Type I error, a Bonfferoni 
adjustment was carried out to minimize the effects of multiple tests.. Post Hoc analysis showed 
a quadratic interaction was observed at set A of measurements but it did not reach statistical 
significance after the Bonfferoni adjustment (p=0.041, alpha<0.025).  
Correlations  
Baseline plasma leptin levels were positively correlated with BMI (r=0.65; p<0.01), Body 
weight (r=0.64; p<0.01), % body fat (r=0.90; p<0.01) and negatively correlated with relative 
(r=-0.82; p<0.01) and absolute (r=-0.59; p<0.05) VO2max. 
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Table 2: Baseline VO2max and anthropometric characteristics (mean±SD).
 
 Control 
(n=7) 
Exercise 
(n=8) 
Age (years) 22.9± 5.1 22.9± 5.8 
Height (m) 1.8± 0.8 1.8± 0.5 
Weight (kg) 109.0± 7.4 104.9± 8.6 
BMI (kg•(m2)-1) 34.5± 3.3 32.5± 2.3 
% Fat 39.9± 5.2 37.1± 6.9 
VO2max (ml•kg-1•min-1) 31.0± 5.0 33.6± 5.6 
VO2max (ml•min-1) 3737± 471 3579± 504 
 
 
 
Table 3: Exercise intensity measurements and energy expenditure estimates (exercise group 
only) (mean±SD).   
 
Exercise HR 
(beats•min-1) 
Exercise 
Intensity 
(ml•kg-1•min-1) 
Exercise 
Intensity 
(% of 
VO2max) 
Total Gross 
Expenditure 
(Kcal) 
Pre-exercise 
BW 
(Kg) 
Post-exercise 
BW 
(Kg) 
140.0± 7.8 19.6± 3.6 58.4± 4.0 567±80 105.1± 9.5 104.9± 9.6 
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Table 4: Leptin and insulin values (mean±SE) before and after the intervention.  
 
 Leptin (ng•ml-1) Insulin (µU•ml-1) 
 Control (n=7) Exercise (n=8) Control (n=7) Exercise (n=8) 
Baseline 1 47.8± 37.1 30.9± 46.0 14.4± 9.7 11.5± 9.7 
Baseline 2 43.8± 35.4 29.2± 41.1 16.4± 10.3 13.6± 9.9 
Pre-exercise 44.1± 35.9 23.5± 30.2 14.4± 10.1 16.1± 9.2 
Post-exercise 40.8± 37.5 24.3± 34.3 14.8± 11.6 8.09± 9.12 
24-h post-exercise 44.7± 36.2 34.9± 66.6 18.4± 8.8 14.3± 9.9 
48-h post-exercise 40.5± 35.4 33.8±64.0 13.04± 9.2 13.8± 10.2 
 
 
 
Table 5: Predicted total daily energy expenditure (TDEE) and actual average total daily energy 
intake (TDEI).  
 
Control (n=7) Exercise (n=8)  
TDEE 
(Kcal) 
TDEI 
(Kcal) 
TDEE 
(Kcal) 
TDEI 
(Kcal) 
4665 4355 3604 3310 
3588 3284 3849 3740 
3974 3862 3753 3556 
3858 3580 3624 3787 
4648 4443 3856 3599 
3283 3325 4463 4090 
4186 - 4109 4314 
  3972 4125 
 
4029±515 3808±503 3904±281 3815±337 
Baseline Leptin and BMI
27.5 30.0 32.5 35.0 37.5 40.0 42.5
0
25
50
75
100
125 r = 0.6458
p = 0.0093
BMI
Le
pt
in
 (n
g/
dl
)
 
Baseline Leptin and Body Weight
175 200 225 250 275 300
0
25
50
75
100
125 r = 0.6412
p = 0.01
Body Weight (kg)
Le
pt
in
 (n
g/
dl
)
 
Figure 1. Correlation between baseline plasma leptin, BMI, and Body weight.  
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Figure 2. Correlation between baseline plasma leptin, %body fat, and VO2max.  
 
 31
Daily Fluctuations in Leptin
Pr
e 1
Pr
e 2
Pr
e 3 Po
st
24
-H
ou
rs 
Po
st
48
-H
ou
rs 
Po
st
0
10
20
30
40
50
60
70
Control
Exercise
Sampling Time Point
Le
pt
in
 (n
g/
dl
)
Daily Fluctuations in Insulin
Pr
e 1
Pr
e 2
Pr
e 3 Po
st
24
-H
ou
rs 
Po
st
48
-H
ou
rs 
Po
st
0
5
10
15
20
25
Control
Exercise
Sampling Time Point
In
su
lin
 ( µ
U
/m
l)
 
Figure 3. Plasma leptin and insulin fluctuations across time. 
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Figure 4. Individual changes in plasma leptin concentration before (pre) and immediately after 
(post) the exercise intervention (exercise group only). 
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DISCUSSION 
Fasting in humans and animals causes a profound decrease in circulating leptin (Boden, Chen, 
Mozzoli, & Ryan, 1996; Considine et al., 1996; Kolaczynski, Ohannesian, Considine, Marco, 
& Caro, 1996; Trayhurn, Thomas, Duncan, & Rayner, 1995), while overfeeding increases 
leptin over a short period of time (Kolaczynski, Ohannesian, Considine, Marco, & Caro, 1996). 
These findings suggest that leptin may be acutely regulated in response to abrupt changes in 
energy intake. Therefore, it is conceivable that other mechanisms that alter energy expenditure 
(i.e. exercise) may also regulate leptin synthesis and secretion. The purpose of this investigation 
was to determine whether moderate energy expenditure induced by an acute exercise session is 
sufficient to alter the levels of circulating leptin immediately after the session, or in the days 
following the exercise intervention. Thus, we tested the effects of an acute exercise bout of 
moderate intensity (50-60% of VO2max), but appropriately long duration (1 hour) to produce 
sufficient energy expenditure, on circulating leptin levels in obese males. The major findings of 
this study are: 1) The Exercise bout had no effect on either plasma leptin or insulin levels 
immediately after, or in 24 and 48 hours post the intervention, and 2) Baseline plasma leptin 
levels positively correlated with BMI, body weight, % body fat and negatively correlated with 
VO2max. No correlations were found between insulin levels and the assessed variables. 
Over the past years, several studies have attempted to elucidate the effects of acute exercise on 
leptin metabolism, but results are inconclusive. Most of the studies have found no significant 
effects on leptin levels after an acute exercise bout of moderate intensity and duration (Fisher, 
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2001; Perusse et al., 1997; Racette, Coppack, Landt, & Klein, 1997; Torjman, Zafeiridis, 
Paolone, Wilkerson, & Considine, 1999; Weltman et al., 2000), while others have detected an 
immediate decrease (Duclos, Corcuff, Ruffie, Roger, & Manier, 1999; Koistinen et al., 1998; 
Landt et al., 1997; Leal-Cerro et al., 1998), or a delayed effect that was demonstrated in the 
days following the intervention (Essig, Alderson, Ferguson, Bartoli, & Durstine, 2000; Olive & 
Miller, 2001; van Aggel-Leijssen, van Baak, Tenenbaum, Campfield, & Saris, 1999). The 
present investigation found no significant changes in leptin levels immediately after or in the 
days following the exercise bout.   
Generally, most of the studies that have demonstrated an immediate acute effect of exercise on 
leptin concentrations have used extremes in duration and/or intensity that resulted in substantial 
energy expenditure (i.e. >1000 Kcals). Landt et al (1997) found that leptin decreased 32% 
immediately after an ultramarathon and 16% at 24 hours post. Similar results were 
demonstrated after 3 hours on an ergometer, or after the completion of a marathon run in fasted 
trained individuals (Koistinen et al., 1998; Leal-Cerro et al., 1998). These studies demonstrate 
that when severe energy deficit is achieved, acute deceases in circulating leptin can be 
observed, at least in lean trained individuals. One hour of cycling at 50% of VO2max did not 
alter leptin concentrations or subcutaneous adipose tissue leptin production in sedentary 
subjects (Racette, Coppack, Landt, & Klein, 1997). Moreover, leptin levels were not modified 
after a submaximal exercise test performed to exhaustion before or after 20 weeks of endurance 
training (Perusse et al., 1997). The disparity among previous investigations could be due to the 
factors (i.e. sample population, intensity, duration) that can affect gross energy expenditure, as 
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well as, factors that affect leptin concentrations including fasting, diurnal effects, and exercise-
induced hemoconcetration.   
To our knowledge, this is the fist attempt to describe the effects of acute exercise on leptin 
concentration in obese individuals. Our study was designed to test whether a typical exercise 
session prescribed for sedentary obese population of moderate intensity, long duration (60 min 
at 60% of VO2max) and sufficient energy expenditure can modulate leptin concentrations. As 
such, our exercise protocol elicited a notable net energy expenditure of approximately 600 Kcal 
with no observed changes in post circulating leptin levels. Consistent with our findings, similar 
exercise-induced energy expenditures (200-530Kcal) produced by variable durations and 
intensities did not alter leptin levels in lean men (Fisher, Van Pelt, Zinder, Landt, & Kohrt, 
2001; Olive & Miller, 2001; Weltman et al., 2000). Moreover, Hilton & Loucks, (2000) 
examined sedentary women when the ~1,400Kcal/day expended by walking was replaced by an 
equivalent dietary intake suggesting that exercise stress without decreased energy availability 
does not affect circulating leptin levels. These results, along with the present data, suggest that 
acute exercise may not affect leptin concentration per se immediately after the intervention. It 
is possible that a threshold for energy deficiency exists that was not reached in the present 
study.         
Despite the absence of an immediate effect of exercise on leptin in most of the studies, some 
investigators have demonstrated delayed effects that are manifested immediately following the 
intervention and up to 48 hours post. Two hours of running at 60-75% of VO2max 
(~1,200Kcal) decreased leptin levels by 30% at 2 hours post exercise in fed runners (Duclos, 
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Corcuff, Ruffie, Roger, & Manier, 1999). Exercise-induced energy expenditure of 800 or 1,500 
Kcal significantly reduced leptin levels 48 hours after an exercise session at 70% of VO2max in 
active men (Essig, Alderson, Ferguson, Bartoli, & Durstine, 2000). Similar decreases in leptin 
were observed in trained lean men 48 hours after endurance exercise at 70% of VO2max that 
induced an energy expenditure of 900 Kcal (Olive & Miller, 2001). Interestingly, in the same 
study these delayed effects were absent when these men performed a maximum exercise 
session that allowed an energy expenditure of only 200 Kcal. A possible explanation for this 
finding is that a threshold level of energy expenditure (i.e.>800 Kcal) may be necessary to 
stimulate an as yet unknown neural or hormonal signal that depresses leptin synthesis or 
secretion.  We failed to demonstrate a delayed effect on leptin concentration at 24 and 48 hours 
after the exercise bout, which may reflect an inadequate level of energy expenditure. Despite 
the importance of exercise-induced energy expenditure in the regulation of leptin levels we 
cannot exclude the possibility that other factors that regulate leptin homeostasis may have 
accounted for the observed results.  
Plasma leptin concentrations change substantially with brief fluctuations in energy intake 
(Boden, Chen, Mozzoli, & Ryan, 1996; Grinspoon et al., 1997; Jenkins, Markovic, Fleury, & 
Campbell, 1997; Kolaczynski, Ohannesian, Considine, Marco, & Caro, 1996), sustained weight 
loss (Christensen, Svendsen, Hassager, & Christiansen, 1998; Okazaki, Himeno, Nanri, Ogata, 
& Ikeda, 1999; Sartorio, Agosti, Resnik, & Lafortuna, 2003), and vary throughout the day 
(Sinha et al., 1996) and between days (Ostlund, Yang, Klein, & Gingerich, 1996). Controlling 
for the above eliminates factors that may mask any exercise-induced effects. We monitored the 
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daily dietary intake in both groups for a week prior to the intervention. In addition, body 
composition was assessed in duplicate (a week before and the day of the intervention) to 
exclude any acute fluctuations in body weight and fat mass, or body hydration. To further 
evaluate the reproducibility of plasma leptin and evaluate possible daily fluctuations in our 
sample population, we used two additional pre-exercise samples assessed during the week 
preceding the intervention. It has also been suggested that the heterogeneity in plasma leptin 
after an exercise session may reflect shifts in plasma volume and control of fed or fasting state 
(Fisher, Van Pelt, Zinder, Landt, & Kohrt, 2001). To account for these factors, all samples were 
assessed after an overnight fast and at the same time of the day (7-9 am), and post exercise 
samples of the experimental group were corrected for changes in hemoconcentration. 
The major difference between our study and all the previous investigations in this area is the 
characteristics of the participants. All previous studies have used lean individuals of variable 
training status, while we used sedentary obese males.  Obese individuals have higher levels of 
the ob mRNA than their lean counterparts (Lonnqvist, Arner, Nordfors, & Schalling, 1995) and 
their leptin concentrations in the peripheral circulation is about four-fold higher compared to 
lean (Considine et al., 1996). Thus, since the expected response to hyperleptinemia is the 
decrease in energy intake and an increase in energy expenditure, most obese individuals may be 
insensitive to the endogenous production of leptin (Caro et al., 1996). These observations 
coupled with the observation that as the degree of obesity increases the variability of leptin 
concentration also increases (Caro et al., 1996b; Considine et al., 1996), suggest that in the 
obese state leptin concentration is affected by factors more than the level of adiposity. For 
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instance, in our study pre-exercise leptin levels at the experimental group vary from 3.0ng/ml to 
95.0ng/ml (mean 23.5±30.2ng/ml), which confirms the heterogeneity of leptin levels among 
our sample population. Thus, it is possible that the interplay between leptin and other 
hormones, that are known to be dysregulated in the obese state, may have contributed to the 
observed variability. 
Obesity is frequently accompanied by hyperinsuliemia and insulin resistance (Girard, 1997; 
Zimmet & Alberti, 1996). Prolonged elevations in insulin under euglycemic conditions increase 
leptin levels (Boden, Chen, Kolaczynski, & Polansky, 1997; Schmitz et al., 1997; Wellhoener 
et al., 2000). As such, it is possible that baseline insulin may have affected the leptin response 
to acute exercise. Participants employed in the present investigation had a normal fasting 
glucose but were not diabetic. We did not demonstrate an association between baseline leptin 
and insulin concentrations that has been previously documented in several studies (Boden, 
Chen, Mozzoli, & Ryan, 1996; Laughlin & Yen, 1997; Malmstrom, Taskinen, Karonen, & Yki-
Jarvinen, 1996; Widjaja et al., 1997). Despite the lack of association between insulin and leptin 
levels in our study, we cannot exclude the possibility that insulin levels may be physiologically 
implicated in leptin metabolism in the obese population. Insulin appears to act directly at the 
level of the adipocyte by increasing leptin expression and secretion (Kieffer & Habener, 2000). 
More importantly, evidence exits that leptin and insulin pathways intersect in skeletal muscle 
(Muoio, Dohm, Tapscott, & Coleman, 1999), which constitutes one of the major tissues 
exhibiting insulin resistance (Tomas et al., 2004). This intersection may be regulated according 
to the relative plasma concentrations of the two hormones and their sensitivity in skeletal 
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muscle. As such, the relative concentrations of leptin and insulin may be particularly important 
especially in light of the fact that leptin directly stimulates fatty-acid oxidation in muscle 
(Minokoshi et al., 2002), an action that is antagonized by insulin (Bryson, Phuyal, Swan, & 
Caterson, 1999; Ceddia, William, Jr., & Curi, 2001; Muoio et al., 1997; Muoio, Dohm, 
Tapscott, & Coleman, 1999). 
Obesity often correlates with abnormalities in the glucocorticoid metabolism (Aldhahi, Mun, & 
Goldfine, 2004; Rosmond, 2005). Increased cortisol levels have been observed immediately 
after acute exercise in humans (Atlaoui et al., 2004; Brandenberger & Follenius, 1975; Duclos 
et al., 1998; Duclos, Corcuff, Pehourcq, & Tabarin, 2001; Duclos, Corcuff, Rashedi, Fougere, 
& Manier, 1997), while glucocorticoid administration has shown to stimulate leptin gene 
expression and secretion independently of effects on food intake (Dagogo-Jack, Selke, Melson, 
& Newcomer, 1997; Miell, Englaro, & Blum, 1996). As such, it is conceivable to speculate that 
exercise-induced increases in cortisol may alter leptin concentrations. In fed males, 45 min of 
intense exercise increased serum cortisol concentration threefold. There was a concomitant 
increase in leptin levels after exercise, which was recovered at 140 min (Fisher, Van Pelt, 
Zinder, Landt, & Kohrt, 2001). Others, however, have not observed changes in leptin levels in 
fed subjects, despite a twofold increase in cortisol levels after 3 hours of exercise. Similarly, 
elevated cortisol levels have been observed immediately post exercise with either no change 
(Essig, Alderson, Ferguson, Bartoli, & Durstine, 2000), or a decrease (Duclos, Corcuff, Ruffie, 
Roger, & Manier, 1999) in leptin levels. The discrepancy of the above results may be attributed 
to physiological factors that have a restraining effect on leptin secretion. Such factors may 
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blunt the stimulatory effects of glucocorticoids on the hormone’s release. For example, 
catecholamines have also been implicated in the regulation of leptin since administration of 
isoprenalin in resting humans significantly reduced basal plasma leptin levels by 81% 
(Donahoo, Jensen, Yost, & Eckel, 1997; Pinkney, Coppack, & Mohamed-Ali, 1998).  
Epinephrine and norepinephrine increase linearly during prolonged (>60min) moderate 
intensity (50-60% of VO2max) exercise (Nybo, Nielsen, Blomstrand, Moller, & Secher, 2003; 
Roy, Green, Grant, & Tarnopolsky, 2001). During exercise in rats, β3-adrenoreceptor blockage 
prevented the reduction in leptin mRNA in retroperitoneal fat (Bramlett et al., 1999; Donahoo, 
Jensen, Yost, & Eckel, 1997), suggesting that sympathetic activity may also regulate leptin 
levels during physical stress. In humans, the effects of catecholamines on leptin levels during 
exercise are not clear at the present time, but in one study plasma catecholamines were related 
to circulating leptin in cyclying women but not in men (Donahoo, Jensen, Yost, & Eckel, 1997; 
Mills, Ziegler, & Morrison, 1998). In another report, however, a 5-day military course 
significantly reduced serum leptin in male soldiers, and this decrease was attributed to the 
exercise-induced sustained elevations in catecholamines (Gomez-Merino, Chennaoui, Drogou, 
Bonneau, & Guezennec, 2002). Similarly, norepinephrine and leptin were correlated in rowers 
after 2 hours recovery from a 90 min session at 75% of VO2max (Desgorces, Chennaoui, 
Gomez-Merino, Drogou, & Guezennec, 2004). Collectively, the aforementioned regulatory 
mechanisms may explain the conflicting data on the impact of exercise on leptin levels, which 
may depend on the intensity and duration of the stress, as well as, the energy availability 
immediately before and during exercise. 
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Baseline plasma leptin concentration positively correlates will all major indices of obesity 
confirming the findings of others that body weight and especially the amount of adipose tissue 
explains most of the variation in fasting leptin levels (Liuzzi et al., 1999; Lonnqvist, Wennlund, 
& Arner, 1997; Niskanen et al., 1997; Ostlund, Yang, Klein, & Gingerich, 1996; Rosenbaum et 
al., 1996). Pre-exercise plasma leptin was also negatively correlated with VO2max, a variable 
that is known to be affected by body weight and body composition. No correlations were 
observed between insulin concentration and the aforementioned variables. 
This project has certain limitations. First, the relatively small sample size that may have 
weakened statistical power. A larger sample size (i.e. n>20) also may have eliminated the large 
individual variability in baseline leptin levels that was present among subjects. Second, despite 
our successful efforts to monitor and control the dietary intake of our subjects by including a 
daily dietary record in the design, we recognize that absolute dietary control can only be 
achieved using individual prescribed meals of particular caloric and nutritional content 
(inpatient metabolic ward). Third, due to the large variability in baseline leptin among subjects 
of both groups, it might have been more appropriate if subjects would have served as their own 
controls in a counterbalanced design.  Finally, this project could have been more sensitive if 
more post-exercise sampling points had been included and if other variables (i.e. 
glucocorticoids) that may affect the leptin response to exercise had also been assessed.  
The potential role of exercise on leptin homeostasis in obese individuals remains elusive. More 
elaborate studies are needed to elucidate whether a threshold of energy expenditure is necessary 
to bring about changes in leptin levels after an exercise bout. Moreover, the potential interplay 
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between leptin and insulin should be further addressed by investigating whether obese insulin-
resistant males have different responses in leptin levels than their healthy counterparts after an 
acute exercise bout or multiple, short-term exercise bouts that are known to improve insulin 
sensitivity.  
In conclusion, we examined the effects of a single exercise session, which induced a notable 
energy deficit, on leptin concentrations in obese males. Exercise had no effect on leptin levels 
immediately after the exercise session, or at 24 and 48 hours post. These results are consistent 
with the notion that a significant decrease in leptin levels can be induced only when a threshold 
of energy expenditure is met and exercise may not be a regulator of leptin concentration per se. 
However, we do not exclude the possibility that other hormonal changes induced by exercise 
may have affected the outcomes.    
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